Participant characteristics, intervention compliance, and clinical tests (n=20)
| Characteristic | Value | ||
| Age (years) | 60±6.9 | ||
| Sex (women/men) | 7/13 | ||
| Exercise sessions completed (%) | 89±12 | ||
| Time in exercise protocol (days) | 69±5 | ||
| Variation from heart rate goal (%) | −0.24±7.12 | ||
| Metric | Pre | Post | P value |
| BMI (kg/m2) | 31.3±4.4 | 30.5±4.1 | 0.139 |
| MNSI physical exam score | 2.9±1.0 | 2.9±1.7 | 0.950 |
| HbA1c (%) | 7.2±1.2 | 7.1±1.3 | 0.770 |
| Fasting glucose (mg/dL) | 139.7±47.5 | 143.4±45.9 | 0.616 |
| Glucose 120 min (mg/dL) | 265.0±104.8 | 257.6±106.0 | 0.378 |
| Matsuda index | 6.0±5.5 | 4.1±2.9 | 0.400 |
| HOMA-IR | 13.9±29.1 | 12.5±22.8 | 0.161 |
| C reactive protein (mg/L) | 4.4±3.7 | 4.7±4.5 | 0.693 |
| VO2peak (mL/kg/min) | 19.4±4.6 | 19.4±4.3 | 0.984 |
Pre indicates preintervention and post indicates postintervention. P indicates statistical differences between preintervention and postintervention values (paired, two-tailed Student’s t-test).
Two VO2 peak data sets were excluded due to scheduling and technical difficulties.
BMI, body mass index; HbA1c, glycosylated hemoglobin; HOMA-IR, homeostasis model assessment of insulin resistance; MNSI, Michigan Neuropathy Screening Instrument.